Nationwide system to centralize decisions around extracorporeal membranous oxygenation use for severe COVID-19 pneumonia in Japan.
作者信息
Takeda Shinhiro
机构信息
Japan ECMOnet for COVID-19 The Japanese Society of Intensive Care Medicine The Japanese Association for Acute Medicine The Japanese Society of Respiratory Care Medicine The Japanese Society of PCPS/ECMO.
出版信息
Acute Med Surg. 2020 Apr 21;7(1):e510. doi: 10.1002/ams2.510. eCollection 2020 Jan-Dec.
Abstract
摘要
相似文献
1
Nationwide system to centralize decisions around extracorporeal membranous oxygenation use for severe COVID-19 pneumonia in Japan.日本用于严重COVID-19肺炎体外膜肺氧合使用决策的全国性系统。
Acute Med Surg. 2020 Apr 21;7(1):e510. doi: 10.1002/ams2.510. eCollection 2020 Jan-Dec.
2
Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence).日本全国范围内集中决策使用体外膜肺氧合治疗重症新冠肺炎的系统（特别报道）
J Intensive Care. 2020 Apr 24;8:29. doi: 10.1186/s40560-020-00445-4. eCollection 2020.
3
Correction to: Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence).对以下内容的更正：日本用于重症 COVID-19 肺炎体外膜肺氧合使用决策的全国性系统（特别通信）。
J Intensive Care. 2020 May 25;8:38. doi: 10.1186/s40560-020-00454-3. eCollection 2020.
4
Safety and Feasibility of Early Physical Therapy for Patients on Extracorporeal Membrane Oxygenator: University of Maryland Medical Center Experience.体外膜肺氧合患者早期物理治疗的安全性和可行性：马里兰大学医学中心的经验
Crit Care Med. 2018 Jan;46(1):53-59. doi: 10.1097/CCM.0000000000002770.
5
Global Trends in Extracorporeal Membranous Oxygenation Use and Survival of Patients With Influenza-Associated Illness.体外膜肺氧合用于流感相关疾病患者的全球趋势及患者生存率
Pediatr Crit Care Med. 2016 Sep;17(9):876-83. doi: 10.1097/PCC.0000000000000843.
6
Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report.体外膜肺氧合治疗重症新型冠状病毒肺炎成功康复：一例报告
Respir Med Case Rep. 2020 May 31;30:101113. doi: 10.1016/j.rmcr.2020.101113. eCollection 2020.
7
Extracorporeal Membrane Oxygenation for Adult Community-Acquired Pneumonia: Outcomes and Predictors of Mortality.成人社区获得性肺炎的体外膜肺氧合：结局与死亡预测因素
Crit Care Med. 2017 May;45(5):814-821. doi: 10.1097/CCM.0000000000002320.
8
Panton-Valentine leukocidin expressing Staphylococcus aureus pneumonia managed with extracorporeal membrane oxygenation: experience and outcome.表达潘顿-瓦伦丁白细胞毒素的金黄色葡萄球菌肺炎通过体外膜肺氧合治疗的经验和结果。
Crit Care Med. 2010 Nov;38(11):2250-3. doi: 10.1097/CCM.0b013e3181f26490.
9
Clinical Applications of Extracorporeal Membranous Oxygenation: A Mini-Review.体外膜肺氧合的临床应用：一篇综述短文
Acta Cardiol Sin. 2014 Nov;30(6):507-13. doi: 10.6515/acs20140821a.
10
Extracorporeal Membrane Oxygenation for Severe Adenoviral Pneumonia in Neonatal, Pediatric, and Adult Patients.体外膜肺氧合在新生儿、儿科和成年患者严重腺病毒肺炎中的应用。
Pediatr Crit Care Med. 2019 Nov;20(11):1078-1084. doi: 10.1097/PCC.0000000000002047.
引用本文的文献
1
Extracorporeal membrane oxygenation (ECMO) in patients with severe COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis.体外膜肺氧合（ECMO）用于重症新型冠状病毒肺炎成人呼吸窘迫综合征患者：一项系统评价与荟萃分析
Cardiothorac Surg. 2021;29(1):9. doi: 10.1186/s43057-021-00046-3. Epub 2021 Apr 12.
2
Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study.关于COVID-19重症急性呼吸窘迫综合征体外膜肺氧合（ECMO）的专家共识声明：一项国际德尔菲研究
Ann Intensive Care. 2023 May 2;13(1):36. doi: 10.1186/s13613-023-01126-9.
3
Clinical epidemiology and outcomes of COVID-19 patients with extracorporeal membrane oxygenation support in Japan: a retrospective study.日本接受体外膜肺氧合支持的COVID-19患者的临床流行病学及预后：一项回顾性研究
IJID Reg. 2022 Jun;3:183-188. doi: 10.1016/j.ijregi.2022.04.001. Epub 2022 Apr 8.
4
COVID-19 ARDS: Points to Be Considered in Mechanical Ventilation and Weaning.新型冠状病毒肺炎急性呼吸窘迫综合征：机械通气与撤机中需考虑的要点
J Pers Med. 2021 Oct 28;11(11):1109. doi: 10.3390/jpm11111109.
5
Extracorporeal Membrane Oxygenation Used in Acute Respiratory Distress Syndrome with COVID-19: A Systematic Review and Meta-Analysis.体外膜肺氧合用于新型冠状病毒肺炎所致急性呼吸窘迫综合征：一项系统评价与Meta分析
J Saudi Heart Assoc. 2021 Jul 2;33(2):177-185. doi: 10.37616/2212-5043.1261. eCollection 2021.
6
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.体外膜肺氧合治疗 COVID-19 的系统评价和荟萃分析。
Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1.
7
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization.体外膜肺氧合治疗 COVID-19：体外生命支持组织 2021 年更新指南。
ASAIO J. 2021 May 1;67(5):485-495. doi: 10.1097/MAT.0000000000001422.
8
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?体外膜肺氧合在2019冠状病毒病患者中的应用：证据是否充分？
J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1256-1262. doi: 10.1053/j.jvca.2020.07.070. Epub 2020 Jul 30.
本文引用的文献
1
Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19.日本新冠病毒体外膜肺氧合网络（Japan ECMOnet for COVID-19）：针对新冠病毒所致严重呼吸衰竭病例的电话会诊
J Intensive Care. 2020 Apr 7;8:24. doi: 10.1186/s40560-020-00440-9. eCollection 2020.
2
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation.为新冠肺炎重症患者做准备：体外膜肺氧合的潜在作用
JAMA. 2020 Apr 7;323(13):1245-1246. doi: 10.1001/jama.2020.2342.
Zotero 插件